OrthoLogic to Host Conference Call Discussing Second Quarter 2008 Operating Results
* Reuters is not responsible for the content in this press release.
TEMPE, Ariz., July 31, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC)
announced today that it will release financial and operating results for the
second quarter ending June 30, 2008, on Thursday, August 7, 2008.
Management will host a conference call and webcast on Thursday, August 7, 2008
at 4:30 pm EDT (3:30 pm CDT, 2:30 pm MDT, 1:30 pm PDT). The call may be accessed
at 800-437-3848 (domestic), 719-457-2089 (international), or by logging onto the
Investors section of the Company's website, http://investor.orthologic.com.
A replay will be available beginning August 7, 2008 at 7:30 pm EDT until
midnight August 9, 2008 and may be accessed at 888-203-1112 (domestic) or
719-457-0820 (international) with replay passcode 1607047.
About OrthoLogic
OrthoLogic is a biotechnology company committed to developing a pipeline of
novel therapeutic peptides aimed at helping patients with under-served medical
conditions. The Company is focused on development and commercialization of two
product platforms: AZX100 and Chrysalin(r) (rusalatide acetate or TP508).
AZX100 is a novel synthetic 24-amino acid peptide, one of a new class of
compounds in the field of smooth muscle relaxation and fibrosis. Based on its
demonstrated effects in pre-clinical models, AZX100 is currently being evaluated
for commercially significant medical applications such as the treatment of
pulmonary disease, the prevention of hypertrophic and keloid scarring and
intimal hyperplasia. OrthoLogic has an exclusive worldwide license to AZX100.
Chrysalin, the Company's novel synthetic 23-amino acid peptide, has been proven
in multiple pre-clinical and clinical models to stimulate cellular events
leading to angiogenesis, revascularization, and repair of dermal and
musculoskeletal tissues. It is currently being evaluated in disorders that
involve vascular endothelial dysfunction. The Company owns exclusive worldwide
rights to Chrysalin.
OrthoLogic's corporate headquarters are in Tempe, Arizona. For more information,
please visit the Company's website: www.orthologic.com.
-0-
CONTACT: OrthoLogic
Investor Relations
Karen Struck
(602) 286-5250
kstruck@olgc.com
The Trout Group
Lauren Glaser
(415) 392-3310
lglaser@troutgroup.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters